Controversies in Localized RCC: Is Taking a Drug for 12 Months and Being Exposed to AEs Worth Having 12 Months of Clean Scans w/o an OS Impact?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Controversies in Localized RCC: Is Taking a Drug for 12 Months and Being Exposed to AEs Worth Having 12 Months of Clean Scans w/o an OS Impact?

By Fox Chase Updates in Bladder and Kidney Cancer 2019 FEATURING Alexander Kutikov

622 views

November 22, 2019

Alexander Kutikov, MD, FACS, Fox Chase Cancer Center, Philadelphia, PA

Dr. Kutikov is Chief of ...
read more ↘ the Division of Urology and Urologic Oncology and a Professor in the Department of Surgical Oncology at Fox Chase Cancer Center. He is a panel member on the American Urological Association’s Prostate Health Committee and part of the Kidney, Bladder, and Prostate Cancer Translational Research Disease Group at Fox Chase. A board-certified, academic urologic surgical oncologist, Dr. Kutikov treats urologic tumors using minimally invasive (robotic/laparoscopic) and traditional surgical techniques. Dr. Kutikov has co-authored more than 200 original manuscripts in peer-reviewed journals. He has published chapters in leading urologic textbooks, including the definitive chapter on adrenal disorders in Campbell-Walsh Urology, and has held leadership positions in the American College of Surgeons, American Urological Association, and Society of Urologic Oncology. He has significant interest in harnessing web and mobile technology to improve patient engagement and quality of care, and is a co-founder of several related ventures.

Dr. Kutikov received his medical degree from Harvard Medical School’s Harvard–MIT Health Sciences and Technology Program. He completed his urologic residency training at University of Pennsylvania and completed a Society of Urologic Oncology fellowship at Fox Chase.
↖ read less

0 Comments